Intelligene News
News
0
Ticker
7832.TWO
ISIN
TW0007832008
Intelligene Eulerpool News
Intelligene Stock News
Intelligene is being monitored by journalists and investors worldwide. We gather the latest Intelligene news here.
Intelligene Stock Press Releases
Intelligene regularly publishes news on the company's website that are relevant for investors.
Intelligene News 2026
This page contains all current news, analysis and press releases for Intelligene stock (7832.TWO, ISIN: TW0007832008). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Intelligene.
Intelligene Stock
Intelligene Intelligene Inc develops innovative RNA gene therapy drugs using siRNA gene compilation technology for treating pneumonia and influenza. The company focuses on research and development of nucleic acid drugs targeting all cases of pneumonia and influenza. Intelligene Inc is a Taiwan-based company with 20 full-time employees operating in the pharmaceutical industry. The company's primary revenue comes from the development and potential commercialization of its RNA-based gene therapy drugs. Intelligene Inc is engaged in the research and development of innovative nucleic acid drugs based on siRNA technology for pneumonia and influenza treatments. The firm aims to provide novel therapeutic solutions for respiratory diseases through its proprietary technology. Intelligene Inc's products target medical professionals and healthcare institutions seeking advanced treatments for pneumonia and influenza. The company's research focuses on developing drugs that address all cases of these respiratory conditions. The firm operates within the pharmaceutical sector with a specific emphasis on RNA-based therapies for respiratory illnesses.